Dr. Anton Scamvougeras

Scamvougeras A, Castle D. Functional Neurological Disorders: Challenging the Mainstream Agnostic Causative Position. The Canadian Journal of Psychiatry. 2024;0(0). doi:10.1177/07067437241245957

https://journals.sagepub.com/doi/10.1177/07067437241245957

Scamvougeras, A; Howard, A. Somatic Symptom Disorder, Medically Unexplained Symptoms, Somatoform Disorders, Functional Neurological Disorder: How DSM-5 Got It Wrong. Can J Psychiatry 2020 May; 65(5): 301-305. doi: 10.1177/0706743720912858

https://journals.sagepub.com/doi/10.1177/0706743720912858

Scamvougeras A, Howard A. Understanding and Managing Somatoform Disorders: A Guide for Clinicians. Vancouver, Canada: AJKS Medical; 2018. 

212 pages. ISBN 978-0-9952056-1-1. 

Open Access pdf available at: 

https://somatoformdisorders.files.wordpress.com/2019/12/understanding-managing-somatoform-disorders-scamvougeras-howard-2018.pdf

Scamvougeras A, Castle D. Are Functional Disorders Driven By Underlying Psychological Distress? Sage perspectives, invited blog, 2024 April 25.

https://perspectivesblog.sagepub.com/blog/research/are-functional-disorders-driven-by-underlying-psychological-distress

Leong, K; Joseph CW Tham, JCW; Scamvougeras, A; Vila-Rodriguez, F. Electroconvulsive therapy treatment in patients with somatic symptom and related disorders. Neuropsychiatr Dis Treat. 2015; 11: 2565–2572

Wald, J; Taylor, S; Scamvougeras, A. Cognitive Behavioural and Neuropsychiatric Treatment of Post-Traumatic Conversion Disorder: a Case Study. Cognitive Behaviour Therapy, 2004, 33, 12–20

Scamvougeras, A; Kigar, DL; Jones, D; Weinberger, DR; Witelson, SF. Size Of The Human Corpus Callosum Is Genetically Determined: An MRI Study In Mono And Dizygotic Twins. Neuroscience Letters, 2003, 338, 91-94.

Scamvougeras, A. Challenging Phenomenology in Tourette’s Syndrome and Obsessive-Compulsive Disorder: The Benefits of Reductionism. Canadian Journal of Psychiatry, 2002, Feb, Bulletin, 17-19

Scamvougeras, A; Greene, SL; Norman, A; Bonomo, Y; Castle, DJ. The fentanyls: a ‘future threat’ for Australia? Australasian Psychiatry, 2020 May 11; 28(5): 545-547. DOI 10.1177/1039856220917074

An Interview with Anton Scamvougeras. Mark Ruffalo, Psychology Today. May 29, 2024.

Part 1: From Conversion to FND: 

https://www.psychologytoday.com/us/blog/from-freud-to-fluoxetine/202405/from-conversion-to-fnd-an-interview-with-anton-scamvougeras

Part 2: Treatment for FND:

https://www.psychologytoday.com/us/blog/from-freud-to-fluoxetine/202405/treatment-for-fnd-an-interview-with-anton-scamvougeras